Apellis Pharmaceuticals
APLS
APLS
73 hedge funds and large institutions have $639M invested in Apellis Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 33 increasing their positions, 4 reducing their positions, and 8 closing their positions.
Holders
73
Holders Change
+25
Holders Change %
+52.08%
% of All Funds
1.67%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
33
Increased
33
Reduced
4
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
76
Norges Bank
Oslo,
Norway
| – | – | -75,000 | Closed |
|
|
MIM
77
MetLife Investment Management
Whippany,
New Jersey
| – | – | -5,716 | Closed |
|
78
DZ Bank
Frankfurt Am Main,
Germany
| – | – | -4,208 | Closed |
|
|
MLICM
79
Metropolitan Life Insurance Company (MetLife)
New York
| – | – | -4,020 | Closed |
|
|
SO
80
STRS Ohio
Columbus,
Ohio
| – | – | -3,100 | Closed |
|
|
TRCT
81
Tower Research Capital (TRC)
New York
| – | – | -405 | Closed |
|